Factor XII does not initiate prekallikrein activation on endothelial cells
- PMID: 9684789
Factor XII does not initiate prekallikrein activation on endothelial cells
Abstract
It is well known that on artificial surfaces, binding and autoactivation of factor XII (FXII) is the initiating event of plasma prekallikrein (PK) activation. We performed investigations to examine whether this mechanism was true for FXII activation on endothelial cells (HUVEC). Activation of PK on HUVEC required an optimal substrate and Zn2+ concentration, the latter of which varied with the buffer's carrier protein. Maximal PK activation required the addition of 250 microM or 10 microM Zn2+ to buffers containing bovine serum albumin (BSA) or gelatin, respectively. However, the actual free Zn2+ concentration in these buffers was the same at 8 microM. In both BSA- and gelatin-containing buffers and using two different chromogenic substrates for FXII, no autoactivation of FXII on HUVEC was seen when incubated for up to 60 min. Rather, initiation of FXII enzymatic activity required the presence of PK. FXII activation after PK activation contributed to the extent of measured enzymatic activity, but its role was secondary because treatment with corn trypsin inhibitor or a neutralizing antibody to FXIIa did not abolish the measured enzymatic activity. They also reduced the activity to the level seen with PK activation alone. Alternatively, soybean trypsin inhibitor abolished the proteolytic activity associated with PK and FXII activation on HUVEC. Further, only normal human and FXII-deficient plasmas, not PK-deficient plasma, had the ability to generate proteolytic activity when incubated over endothelial cells. In a purified system, maximal PK activation was measured after a 10-15 min incubation depending upon the concentration of reactants. When FXII was added with the PK, maximal activation occurred within 7.5-10 min. In normal human or FXII-deficient plasmas, but not in PK-deficient plasma, maximal activation was seen in 4 min. These data indicate that on HUVEC, unlike artificial surfaces, PK activation when bound to HK is the initiating activation event in this system. FXII activation is secondary to PK activation and contributes to the extent of measured enzymatic activity. These data challenge the accepted dogmas of "contact activation" and suggest that on biologic membranes a new notion as to how this system is activated needs to be considered.
Similar articles
-
Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix.Thromb Haemost. 2001 Sep;86(3):840-7. Thromb Haemost. 2001. PMID: 11583317
-
The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.Thromb Haemost. 1999 Sep;82(3):1033-40. Thromb Haemost. 1999. PMID: 10494760
-
Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).Blood Coagul Fibrinolysis. 1993 Oct;4(5):671-8. Blood Coagul Fibrinolysis. 1993. PMID: 7507361
-
Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.Biochem Pharmacol. 2008 Mar 1;75(5):1007-13. doi: 10.1016/j.bcp.2007.10.003. Epub 2007 Oct 7. Biochem Pharmacol. 2008. PMID: 17996217 Review.
-
Proteolytic activity of contact factor zymogens.J Thromb Haemost. 2021 Feb;19(2):330-341. doi: 10.1111/jth.15149. Epub 2020 Dec 7. J Thromb Haemost. 2021. PMID: 33107140 Free PMC article. Review.
Cited by
-
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047. J Allergy Clin Immunol. 2004. PMID: 15356535 Free PMC article.
-
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6. Clin Rev Allergy Immunol. 2021. PMID: 33956309 Free PMC article. Review.
-
A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.Am J Pathol. 2004 Sep;165(3):969-76. doi: 10.1016/S0002-9440(10)63358-5. Am J Pathol. 2004. PMID: 15331420 Free PMC article.
-
Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans.Front Physiol. 2017 Jul 11;8:481. doi: 10.3389/fphys.2017.00481. eCollection 2017. Front Physiol. 2017. PMID: 28744223 Free PMC article. Review.
-
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.Clin Rev Allergy Immunol. 2016 Oct;51(2):207-15. doi: 10.1007/s12016-016-8555-6. Clin Rev Allergy Immunol. 2016. PMID: 27273087 Review.